Pharmaceutical Company

NJ 2024 Independent Pharmacies

DOJ False Claims Act Anti Kickback Conspiracy

Penalty

$30 million

Outcome

Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug

Details

Pharmaceutical Company — DOJ Enforcement (2024)

DOJ took enforcement action against Pharmaceutical Company in NJ in 2024 involving false claims act, anti kickback, conspiracy violations in the Independent Pharmacies sector.

Penalty: $30 million

Violation types: False Claims Act, Anti Kickback, Conspiracy
Entity type: Pharmacy
Penalty type: Criminal
Location: NJ

Source: DOJ Press Release — Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works